North American Vaccine regulatory update

The FDA’s Vaccines and Related Biologicals Panel will review NVX’s DTaP vaccine at its Oct. 29 meeting. The panel is reviewing the product, a diphtheria, tetanus, and acellular pertussis vaccine, as a...